Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency

Karl Mikael Kälkner (), Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung and Veronica Arthurson
Additional contact information
Karl Mikael Kälkner: Swedish Medical Products Agency
Anders Sundström: Swedish Medical Products Agency
Marja-Leena Nurminen: Swedish Medical Products Agency
Maria Larsson: Swedish Medical Products Agency
Rickard Ljung: Swedish Medical Products Agency
Veronica Arthurson: Swedish Medical Products Agency

Drug Safety, 2023, vol. 46, issue 3, No 8, 319-321

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01275-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:3:d:10.1007_s40264-023-01275-7

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01275-7

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().